DarioHealth (NASDAQ:DRIO) Stock Price Crosses Above Fifty Day Moving Average – Here’s What Happened

DarioHealth Corp. (NASDAQ:DRIOGet Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $10.60 and traded as high as $16.55. DarioHealth shares last traded at $15.69, with a volume of 56,778 shares trading hands.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of DarioHealth in a research report on Wednesday. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, DarioHealth presently has a consensus rating of “Hold” and a consensus target price of $40.00.

Get Our Latest Stock Report on DRIO

DarioHealth Stock Down 4.2%

The firm’s fifty day moving average price is $10.60 and its 200-day moving average price is $12.64. The company has a market capitalization of $35.62 million, a price-to-earnings ratio of -1.19 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a current ratio of 3.30 and a quick ratio of 2.83.

Institutional Inflows and Outflows

An institutional investor recently raised its position in DarioHealth stock. XTX Topco Ltd lifted its stake in shares of DarioHealth Corp. (NASDAQ:DRIOFree Report) by 229.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 62,511 shares of the company’s stock after buying an additional 43,513 shares during the period. XTX Topco Ltd owned about 0.14% of DarioHealth worth $42,000 as of its most recent SEC filing. Institutional investors and hedge funds own 33.39% of the company’s stock.

DarioHealth Company Profile

(Get Free Report)

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

See Also

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.